Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Neurology 2, 7 (1 January 2006) | doi:10.1038/ncpneuro0065
Novel approach to immunotherapy for Alzheimer's disease
Abstract
Frenkel D et al. (2005) Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears β-amyloid in a mouse model of Alzheimer disease. J Clin Invest 115: 2423–2433 A novel potential vaccination treatment for Alzheimer's disease (AD) was recently described by Frenkel and colleagues.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
